Stock & Company Details
Natera Inc $NTRA
Price:
N/A
N/A
144M
$56B
52 Week High:
N/A
10 Day Average Volume:
N/A
-286.25
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
NTRA technical indicators
Latest Natera Inc (NTRA) indicator readings as of 2026-10-09.
NTRA's 14-day RSI is 61.2, in neutral territory. At $400.71 it is trading 58.1% above its 200-day moving average of $253.39, and above its 50-day average of $345.42. Price sits in the middle of its Bollinger Bands ($342.03 to $439.87). ADX reads 53.6, indicating a trending market.
NTRA backtested strategy results
How 4 rule-based strategies performed on Natera Inc (NTRA) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | -54.8% | 14% | 7 | -63.8% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +253.5% | 37% | 27 | -43.7% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +81.9% | 42% | 31 | -22.3% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +26.0% | 63% | 24 | -60.7% |
Overview
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform.
Finance Bot
Ask your questions
Start by typing a question below.
